Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Dengue Vaccine Market Size, Share and Growth Outlook, 2026: Analysis By Vaccine Type (Live Attenuated Vaccines, Chimeric Live Attenuated Vaccines, Recombinant Subunit Vaccines, Nucleic Acid-based Vaccines), By Route of Administration (Parenteral , Oral), By End User (Hospitals, Public Health Institutes and Government Agencies, Specialized Vaccination Clinics, Non-Governmental Organizations) Companies, and Country Forecast, 2021 to 2034

Global Dengue Vaccine Market size is forecast to increase from $971.38 Million in 2026 to $3097.79 Million in 2034 at a CAGR of 15.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006667
Pages: 216 Pages

Dengue Testing Market Size, Share and Growth Outlook, 2026: Analysis By Diagnostic Technology (NS1 Antigen Testing Kits, IgM, RT-PCR Molecular Tests, Multiplex Combination ), By Sample Matrix (Serum and Plasma, Whole Blood , Saliva and Oral Fluids), By Test Environment Model (Laboratory-Based High-Throughput Diagnostics, Point-of-Care Testing , Over-the-Counter ), By End-User Facility (Hospitals and Acute Care Clinics, Commercial & Reference Diagnostic Laboratories, Public Health Agencies & Epidemiological Surveillance Programs) Companies, and Country Forecast, 2021 to 2034

Global Dengue Testing Market size is forecast to increase from $505.13 Million in 2026 to $787.05 Million in 2034 at a CAGR of 5.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006666
Pages: 218 Pages

Dendritic Cell Cancer Vaccine Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Sipuleucel-T, CreaVax, Other Clinical-Stage Pipeline Variants), By Cancer Indication (Prostate Cancer, Melanoma, Glioblastoma, Renal Cell Carcinoma, Other Solid Tumors), By Donor Source (Autologous Dendritic Cell Vaccines, Allogeneic Dendritic Cell Vaccines), By Patient Demographics (Adult Patients, Pediatric Patients) Companies, and Country Forecast, 2021 to 2034

Global Dendritic Cell Cancer Vaccine Market size is forecast to increase from $359.49 Million in 2026 to $787.57 Million in 2034 at a CAGR of 10.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006665
Pages: 218 Pages

Demineralized Bone Matrix Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Putty Formulations, Gel Formulations, Demineralized Cortical Fibers, Paste and Crunch Formats), By Tissue Form (Cortical Allograft, Cancellous Allograft, Combined Allograft & Synthetics), By Clinical Application (Spinal Fusion, Dental Procedures & Oral Surgery, Joint Reconstruction, Craniomaxillofacial Surgery, Trauma & Extremities Surgery), By End-User (Hospitals and Surgical Centers, Specialty Orthopedic Centers, Dental Clinics) Companies, and Country Forecast, 2021 to 2034

Global Demineralized Bone Matrix Market size is forecast to increase from $1.7 Billion in 2026 to $2.75 Billion in 2034 at a CAGR of 6.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006664
Pages: 219 Pages

Dementia Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class: (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Anti-Amyloid Monoclonal Antibodies, MAO Inhibitors, Multi-target Kinase Inhibitors), By Indication: (Alzheimer's Disease, Parkinson's Disease Dementia, Lewy-Body Dementia, Frontotemporal Dementia, Mild Cognitive Impairment), By Route of Administration: (Oral, Intravenous, Transdermal), By Distribution Channel: (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Dementia Drugs Market size is forecast to increase from $21.42 Billion in 2026 to $40.54 Billion in 2034 at a CAGR of 8.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006663
Pages: 215 Pages

Dementia and Movement Disorder Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Disorder Type: (Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Vascular Dementia, Dementia with Lewy Bodies, Frontotemporal Dementia), By Therapy Type: (Pharmacotherapy, Cognitive Therapy, Occupational, Neurostimulation, Digital Therapeutics), By Route of Administration: (Oral, Intravenous, Transdermal), By End-User: (Hospitals, Specialty Neurological Clinics, Long-term Care Facilities, Home Care Settings) Companies, and Country Forecast, 2021 to 2034

Global Dementia and Movement Disorder Treatment Market size is forecast to increase from $23 Billion in 2026 to $41.33 Billion in 2034 at a CAGR of 7.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006662
Pages: 215 Pages

De-identified Health Data Market Size, Share and Growth Outlook, 2026: Analysis By Data Type: (Clinical Data, Genomic Data, Imaging Data, Claims, Pharmaceutical), By Application: (Clinical Research and Trials, Drug Discovery and Development, Precision Medicine, Population Health Management, Outcome Modeling and Risk Prediction), By End-User: (Pharmaceutical Companies, Biotechnology Firms, Medical Device Manufacturers, Healthcare Providers, Insurance Companies , Research Institutions, Government Agencies) Companies, and Country Forecast, 2021 to 2034

Global De-identified Health Data Market size is forecast to increase from $10.2 Billion in 2026 to $21.55 Billion in 2034 at a CAGR of 9.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006661
Pages: 224 Pages

Degenerative Disc Disease Market Size, Share and Growth Outlook, 2026: Analysis By Treatment Type (Pharmacological Therapy , Surgical Treatment , Non-Surgical Modalities , Biologic), By Product Type (Spinal Fixation Devices, Artificial Discs , Bone Graft Substitutes, Tissue-engineered Products), By Application (Cervical Disc Degeneration, Lumbar Disc Degeneration, Thoracic Disc Degeneration), By End User (Hospitals, Specialty Orthopedic and Spine Clinics, Ambulatory Surgical Centers , Rehabilitation and Physiotherapy Centers) Companies, and Country Forecast, 2021 to 2034

Global Degenerative Disc Disease Market size is forecast to increase from $2.6 Billion in 2026 to $4.92 Billion in 2034 at a CAGR of 8.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006660
Pages: 229 Pages

Deflectable Catheters Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Uni-directional Catheters, Bi-directional Catheters, Multi-directional Catheters), By Material (Pebax and Polyurethane Blends, PTFE and ePTFE, Nitinol-Reinforced Composites), By Application (Coronary Interventions, Electrophysiology , Diagnostic Imaging, Peripheral Interventions, Structural Heart and TAVI Support), By End User (Hospitals and Cardiac Centers, Ambulatory Surgical Centers , Specialized Catheterization Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Deflectable Catheters Market size is forecast to increase from $2.42 Billion in 2026 to $3.63 Billion in 2034 at a CAGR of 5.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006659
Pages: 225 Pages

Defibrillator Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Implantable Cardioverter Defibrillators , External Defibrillators ), By Patient Type (Adult Patients, Pediatric Patients), By End User (Hospitals and Cardiac Centers, Pre-hospital Settings , Public Access Markets , Home Care Settings) Companies, and Country Forecast, 2021 to 2034

Global Defibrillator Market size is forecast to increase from $8.39 Billion in 2026 to $15.88 Billion in 2034 at a CAGR of 8.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006658
Pages: 210 Pages